Literature DB >> 15148568

Practices in non-neutropenic ICU patients with Candida-positive airway specimens.

Elie Azoulay1, Yves Cohen, Jean-Ralph Zahar, Maité Garrouste-Orgeas, Christophe Adrie, Pierre Moine, Arnaud de Lassence, Jean-François Timsit.   

Abstract

OBJECTIVE: To examine practices of French intensivists regarding the management of mechanically ventilated patients with Candida-positive airway specimens but no major risk factors for immunodepression. Design : Closed-item questionnaire with a clinical vignette.
SETTING: 564 French intensive care units (ICUs). PARTICIPANTS: 198 intensivists who have a special interest in infectious diseases and who answered the questionnaire (response rate, 35.1%). INTERVENTION: None. MEASUREMENTS AND
RESULTS: The respondents recommended bronchoalveolar lavage (62.6% of respondents), protected distal sampling and protected specimen brush (59.1%), transbronchial biopsy (38.9%), and tracheal aspiration (12.1%) for the diagnosis of candidal pneumonia. A positive airway specimen was felt by most respondents (83.3%) to indicate colonisation; 66.7% of respondents recommended tests for systemic candidiasis in this situation, and 56.5% serial sampling to compute the colonisation index. Azole derivatives were the preferred antifungal medications. The clinical vignette described a patient with chronic obstructive lung disease who required mechanical ventilation for an acute exacerbation and who had a tracheal aspirate positive for Candida. Responses varied widely, with 37.8% of respondents diagnosing clinically insignificant colonisation but 24.2% recommending antifungal treatment and 61.6% serial testing to assess the Candida colonisation index. Intensivists with greater experience with severely immunocompromised patients were more aggressive in their diagnostic management.
CONCLUSIONS: Wide variations occur among practices of French intensivists regarding Candida-positive airway specimens in patients without major risk factors for immunodepression. Additional studies are needed to improve our understanding of the links between Candida colonisation and infection and to determine the indications for pre-emptive antifungal treatment in non-neutropenic critically ill patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15148568     DOI: 10.1007/s00134-004-2316-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  31 in total

1.  Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study.

Authors:  M el-Ebiary; A Torres; N Fàbregas; J P de la Bellacasa; J González; J Ramirez; D del Baño; C Hernández; M T Jiménez de Anta
Journal:  Am J Respir Crit Care Med       Date:  1997-08       Impact factor: 21.405

Review 2.  Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care.

Authors:  J L Vincent; E Anaissie; H Bruining; W Demajo; M el-Ebiary; J Haber; Y Hiramatsu; G Nitenberg; P O Nyström; D Pittet; T Rogers; P Sandven; G Sganga; M D Schaller; J Solomkin
Journal:  Intensive Care Med       Date:  1998-03       Impact factor: 17.440

3.  Impairment of polymorphonuclear neutrophil functions precedes nosocomial infections in critically ill patients.

Authors:  François Stephan; Kun Yang; Jacques Tankovic; Claude-James Soussy; Gilles Dhonneur; Philippe Duvaldestin; Laurent Brochard; Christian Brun-Buisson; Alain Harf; Christophe Delclaux
Journal:  Crit Care Med       Date:  2002-02       Impact factor: 7.598

4.  Mechanisms for the diminished neutrophil exudation to secondary inflammatory sites in infected patients with a systemic inflammatory response (sepsis).

Authors:  N A Ahmed; S McGill; J Yee; F Hu; R P Michel; N V Christou
Journal:  Crit Care Med       Date:  1999-11       Impact factor: 7.598

5.  Pulmonary fungal infection: emphasis on microbiological spectra, patient outcome, and prognostic factors.

Authors:  K Y Chen; S C Ko; P R Hsueh; K T Luh; P C Yang
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

6.  Candida sepsis in surgical patients.

Authors:  P J Eubanks; C de Virgilio; S Klein; F Bongard
Journal:  Am J Surg       Date:  1993-12       Impact factor: 2.565

7.  Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial.

Authors:  D J Winston; P H Chandrasekar; H M Lazarus; J L Goodman; J L Silber; H Horowitz; R K Shadduck; C S Rosenfeld; W G Ho; M Z Islam; D N Buell
Journal:  Ann Intern Med       Date:  1993-04-01       Impact factor: 25.391

8.  Candidiasis in cancer patients.

Authors:  G P Bodey
Journal:  Am J Med       Date:  1984-10-30       Impact factor: 4.965

9.  The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.

Authors:  J L Vincent; D J Bihari; P M Suter; H A Bruining; J White; M H Nicolas-Chanoin; M Wolff; R C Spencer; M Hemmer
Journal:  JAMA       Date:  1995 Aug 23-30       Impact factor: 56.272

Review 10.  Primary Candida pneumonia. Experience at a large cancer center and review of the literature.

Authors:  E Haron; S Vartivarian; E Anaissie; R Dekmezian; G P Bodey
Journal:  Medicine (Baltimore)       Date:  1993-05       Impact factor: 1.889

View more
  18 in total

1.  Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study.

Authors:  W Meersseman; K Lagrou; I Spriet; J Maertens; E Verbeken; W E Peetermans; E Van Wijngaerden
Journal:  Intensive Care Med       Date:  2009-04-09       Impact factor: 17.440

2.  Candida pneumonia in the ICU: myth or reality?

Authors:  Jean-Damien Ricard; Damien Roux
Journal:  Intensive Care Med       Date:  2009-06-27       Impact factor: 17.440

Review 3.  Epidemiology, incidence and risk factors for invasive candidiasis in high-risk patients.

Authors:  Ercole Concia; Anna Maria Azzini; Michela Conti
Journal:  Drugs       Date:  2009       Impact factor: 9.546

4.  Impact of bronchial colonization with Candida spp. on the risk of bacterial ventilator-associated pneumonia in the ICU: the FUNGIBACT prospective cohort study.

Authors:  Jean-Francois Timsit; Carole Schwebel; Lenka Styfalova; Muriel Cornet; Philippe Poirier; Christiane Forrestier; Stéphane Ruckly; Marie-Christine Jacob; Bertrand Souweine
Journal:  Intensive Care Med       Date:  2019-04-24       Impact factor: 17.440

Review 5.  [Update: invasive fungal infections: Diagnosis and treatment in surgical intensive care medicine].

Authors:  C Lichtenstern; S Swoboda; M Hirschburger; E Domann; T Hoppe-Tichy; M Winkler; C Lass-Flörl; M A Weigand
Journal:  Anaesthesist       Date:  2010-01       Impact factor: 1.041

Review 6.  Year in review in Intensive Care Medicine 2009: I. Pneumonia and infections, sepsis, outcome, acute renal failure and acid base, nutrition and glycaemic control.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2010-01-08       Impact factor: 17.440

7.  Candida sp. isolated from bronchoalveolar lavage: clinical significance in critically ill trauma patients.

Authors:  G Christopher Wood; Eric W Mueller; Martin A Croce; Bradley A Boucher; Timothy C Fabian
Journal:  Intensive Care Med       Date:  2006-02-14       Impact factor: 17.440

Review 8.  Invasive candidiasis in pediatric intensive care patients: epidemiology, risk factors, management, and outcome.

Authors:  Joanna Filioti; Kleomenis Spiroglou; Emmanuel Roilides
Journal:  Intensive Care Med       Date:  2007-05-15       Impact factor: 17.440

9.  Respiratory Tract Colonization by Candida species Portends Worse Outcomes in Immunocompromised Patients.

Authors:  Kathryn M Pendleton; Robert P Dickson; Duane W Newton; Timothy C Hoffman; Gregory A Yanik; Gary B Huffnagle
Journal:  Clin Pulm Med       Date:  2018-11

10.  Diagnostic importance of pulmonary interleukin-1beta and interleukin-8 in ventilator-associated pneumonia.

Authors:  Andrew Conway Morris; Kallirroi Kefala; Thomas S Wilkinson; Olga Lucia Moncayo-Nieto; Kevin Dhaliwal; Lesley Farrell; Timothy S Walsh; Simon J Mackenzie; David G Swann; Peter J D Andrews; Niall Anderson; John R W Govan; Ian F Laurenson; Hamish Reid; Donald J Davidson; Christopher Haslett; Jean-Michel Sallenave; A John Simpson
Journal:  Thorax       Date:  2009-10-12       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.